HOME / Teaching staff / Teachers profile

Mirjana Bećarević



Full Professor

Faculty of Medicine, Department of Pharmacy

mirjana.becarevic@mf.uns.ac.rs

Phone: 021422760

ORCID ID : 0000-0003-2114-8621



Academic career Year Institution Field

Status Acquired

2018

Faculty of Medicine Novi Sad

Pharmacy

PhD

2007

Faculty of Pharmacy Beograd

Pharmacy

MSc

2005

Faculty of Pharmacy Beograd

Pharmacy

Graduated

2000

Faculty of Pharmacy Beograd

Pharmacy

M Description

22

Bećarević M. Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha. J Thromb Thrombolysis 2017; 44:565-70. issn: 0929-5305

22

Bećarević M. Antibodies against complement components: relevance for the antiphospholipid syndrome-biomarkers of the disease and biopharmaceuticals. Curr Rheumatol Rep 2017;19(40):1-9.

21

Bećarević M, Majkić-Singh N. High-sensitivity C-reactive protein: discriminator between patients with primary and secondary antiphospholipid syndrome. Clin Biochem 2008; 41: 1449 – 53.

22

Bećarević M, Andrejević S, Miljić P, Bonači-Nikolić B, Majkić-Singh N. Serum lipids and anti-oxidized LDL antibodies in primary antiphospholipid syndrome. Clin Exp Rheumatol 2007; 25 (3): 361 – 6.

22

Bećarević M, Seferović J, Ignjatović S, Singh S, Majkić-Singh N. Significant association of antiphospholipid antibodies and TNF-alpha: marker of severe atherogenic profile of patients with type II diabetes mellitus without micro and/or macrovascular complications. Cytokine 2011; 55: 301 – 306.

22

Bećarević M, Singh S, Majkić-Singh N. Oxidized LDL, anti-oxidized LDL and anti-annexin A5 antibodies in primary antiphospholipid syndrome. Clin Lab 2008; 54: 97 – 101.

22

Poša M, Pilipović A, Bećarević M, Farkaš Z. pKa values of hyodeoxycholic and cholic acids in the binary mixed micelles sodium-hyodeoxycholate–Tween 40 and sodium-cholate–Tween 40: Thermodynamic stability of the micelle and the cooperative hydrogen bond formation with the steroid skeleton. Steroids 2017; 117:62-70.

22

Bećarević M. The IgG and IgM isotypes of anti-annexin A5 antibodies: relevance for primary antiphospholipid syndrome. J Thromb Thrombolysis 2016; 42(4):552-557.

23

Bećarević M, Nikolić B, Ignjatović S. Adiponectin: a therapeutic target in the antiphospholipid syndrome? 2019; Rheumatol Int DOI 10.1007/s00296-019-04349-x.

21

Bećarević M, Singh S, Majkić-Singh N. Lipoprotein (a) and Apolipoprotein (a) in Primary Antiphospholipid Syndrome. Clin Biochem 2007; 40: 317 − 20.

Course Studies

Biopharmacy 1

Integrated academic studies of Pharmacy

Biopharmacy 2

Integrated academic studies of Pharmacy